Despite the well-characterized role of HSF1 in cancer development and progression [13, 12, 22, 23], in the context of PKCθ activation and the inhibition of the insulin pathway, non-heat-shock HSF1 activation appears to provide a therapeutic advantage. The gene discussed is HSF1; the disease is cancer.